Cover Page - Shares Shares in Thousands Entity Information (Line Items)

Cover Page - shares shares in Thousands
Entity Information [Line Items]

Document Type
Document Quarterly Report
Document Period End Date
Document Transition Report
Entity File Number
Entity Registrant Name
Entity Incorporation, State or Country Code
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Postal Zip Code
City Area Code
Local Phone Number
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Entity Shell Company
Entity Common Stock, Shares Outstanding (in shares)
Amendment Flag
Document Fiscal Year Focus
Document Fiscal Period Focus
Entity Central Index Key
Current Fiscal Year End Date
Common Stock
Title of 12(b) Security
Trading Symbol
Security Exchange Name
1.000% Notes due 2022
No Trading Symbol Flag
1.375% Notes due 2024
0.000% Notes due 2025
0.875% Notes due 2025
1.625% Notes due 2026
2.000% Notes due 2027
1.375% Notes due 2029
3.050% Notes due 2029
0.500% Notes due 2031
3.600% Notes due 2042
3 Months Ended
Dec. 25, 2021 Jan. 14, 2022
10-Q
true
Dec. 25,
false 2021
001-36743
Apple Inc.
CA
94-2404110
One Apple Park Way
Cupertino
CA
95014
408
996-1010
Yes
Yes
Large Accelerated Filer
false
false
false
16,319,441
false
2022
Q1
0000320193
--09-24
Common Stock, $0.00001 par value per share

AAPL
NASDAQ
1.000% Notes due 2022

true
NASDAQ
1.375% Notes due 2024

true
NASDAQ
0.000% Notes due 2025

true
NASDAQ
0.875% Notes due 2025

true
NASDAQ
1.625% Notes due 2026

true
NASDAQ
2.000% Notes due 2027

true
NASDAQ
1.375% Notes due 2029

true
NASDAQ
3.050% Notes due 2029

true
NASDAQ
0.500% Notes due 2031

true
NASDAQ
3.600% Notes due 2042

true
NASDAQ
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Millions
Net sales
Cost of sales
Gross margin
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Other income/(expense), net
Income before provision for income taxes
Provision for income taxes
Net income
Earnings Per Share [Abstract]
Basic (in dollars per share)
Diluted (in dollars per share)
Shares used in computing earnings per share:
Basic (in shares)
Diluted (in shares)
Products
Net sales
Cost of sales
Services
Net sales
Cost of sales
3 Months Ended
Dec. 25, 2021 Dec. 26, 2020
$ 123,945 $ 111,439
69,702 67,111
54,243 44,328
6,306 5,163
6,449 5,631
12,755 10,794
41,488 33,534
(247) 45
41,241 33,579
6,611 4,824
$ 34,630 $ 28,755
$ 2.11 $ 1.70
$ 2.10 $ 1.68
16,391,724 16,935,119
16,519,291 17,113,688
$ 104,429 $ 95,678
64,309 62,130
19,516 15,761
$ 5,393 $ 4,981
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) -
USD ($) $ in Millions
Statement of Comprehensive Income [Abstract]
Net income
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax
Change in unrealized gains/losses on derivative instruments, net of tax:
Change in fair value of derivative instruments
Adjustment for net (gains)/losses realized and included in net income
Total change in unrealized gains/losses on derivative instruments
Change in unrealized gains/losses on marketable debt securities, net of tax:
Change in fair value of marketable debt securities
Adjustment for net (gains)/losses realized and included in net income
Total change in unrealized gains/losses on marketable debt securities
Total other comprehensive income/(loss)
Total comprehensive income
3 Months Ended
Dec. 25, 2021 Dec. 26, 2020
$ 34,630 $ 28,755
(360) 549
362 (304)
93 (183)
455 (487)
(1,176) 628
(9) (105)
(1,185) 523
(1,090) 585
$ 33,540 $ 29,340
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions
Current assets:
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Inventories
Vendor non-trade receivables
Other current assets
Total current assets
Non-current assets:
Marketable securities
Property, plant and equipment, net
Other non-current assets
Total non-current assets
Total assets
Current liabilities:
Accounts payable
Other current liabilities
Deferred revenue
Commercial paper
Term debt
Total current liabilities
Non-current liabilities:
Term debt
Other non-current liabilities
Total non-current liabilities
Total liabilities
Commitments and contingencies
Shareholders’ equity:
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares
authorized; 16,340,851 and 16,426,786 shares issued and outstanding, respectively
Retained earnings
Accumulated other comprehensive income/(loss)
Total shareholders’ equity
Total liabilities and shareholders’ equity
Dec. 25, 2021 Sep. 25, 2021
$ 37,119 $ 34,940
26,794 27,699
30,213 26,278
5,876 6,580
35,040 25,228
18,112 14,111
153,154 134,836
138,683 127,877
39,245 39,440
50,109 48,849
228,037 216,166
381,191 351,002
74,362 54,763
49,167 47,493
7,876 7,612
5,000 6,000
11,169 9,613
147,574 125,481
106,629 109,106
55,056 53,325
161,685 162,431
309,259 287,912
58,424 57,365
14,435 5,562
(927) 163
71,932 63,090
$ 381,191 $ 351,002
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ /
shares
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)
Common stock, shares authorized (in shares)
Common stock, shares issued (in shares)
Common stock, shares outstanding (in shares)
Dec. 25, 2021 Sep. 25, 2021
$ 0.00001 $ 0.00001
### ###
### ###
### ###
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) -
Beginning balances at Sep. 26, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock withheld related to net share settlement of equity awards
Share-based compensation
Net income
Dividends and dividend equivalents declared
Common stock repurchased
Other comprehensive income/(loss)
Ending balances at Dec. 26, 2020
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)
Beginning balances at Sep. 25, 2021
Common stock withheld related to net share settlement of equity awards
Share-based compensation
Net income
Dividends and dividend equivalents declared
Common stock repurchased
Other comprehensive income/(loss)
Ending balances at Dec. 25, 2021
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)
Total Common stock and additional paid-in capital Retained earnings
$ 65,339 $ 50,779 $ 14,966
(1,101) (1,873)
2,066
28,755 28,755
(3,547)
(24,000)
585
$ 66,224 51,744 14,301
$ 0.205
$ 63,090 57,365 5,562
(1,263) (1,730)
2,322
34,630 34,630
(3,665)
(20,400) (20,362)
(1,090)
$ 71,932 $ 58,424 $ 14,435
$ 0.22
Accumulated other comprehensive income/(loss)
$ (406)
585
179
163
(1,090)
$ (927)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in
Millions
Statement of Cash Flows [Abstract]
Cash, cash equivalents and restricted cash, beginning balances
Operating activities:
Net income
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
Share-based compensation expense
Deferred income tax expense/(benefit)
Other
Changes in operating assets and liabilities:
Accounts receivable, net
Inventories
Vendor non-trade receivables
Other current and non-current assets
Accounts payable
Deferred revenue
Other current and non-current liabilities
Cash generated by operating activities
Investing activities:
Purchases of marketable securities
Proceeds from maturities of marketable securities
Proceeds from sales of marketable securities
Payments for acquisition of property, plant and equipment
Other
Cash used in investing activities
Financing activities:
Payments for taxes related to net share settlement of equity awards
Payments for dividends and dividend equivalents
Repurchases of common stock
Repayments of term debt
Proceeds from/(Repayments of) commercial paper, net
Other
Cash used in financing activities
Increase/(Decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, ending balances
Supplemental cash flow disclosure:
Cash paid for income taxes, net
Cash paid for interest
3 Months Ended
Dec. 25, 2021 Dec. 26, 2020
$ 35,929 $ 39,789
34,630 28,755
2,697 2,666
2,265 2,020
682 (58)
167 25
(3,934) (10,945)
681 (950)
(9,812) (10,194)
(4,921) (3,526)
19,813 21,670
462 1,341
4,236 7,959
46,966 38,763
(34,913) (39,800)
11,309 25,177
10,675 9,344
(2,803) (3,500)
(374) 195
(16,106) (8,584)
(2,888) (2,861)
(3,732) (3,613)
(20,478) (24,775)
0 (1,000)
(1,000) 22
(61) (22)
(28,159) (32,249)
2,701 (2,070)
38,630 37,719
5,235 1,787
$ 531 $ 619
Summary of Significant Accounting Policies
Accounting Policies [Abstract]
Summary of Significant Accounting Policies
3 Months Ended
Dec. 25, 2021
Summary of Significant Accounting Policies Basis of Presentation and Preparation The

condensed consolidated financial statements include the accounts of Apple Inc. and its wholly
Revenue
Revenue from Contract with Customer [Abstract]
Revenue
3 Months Ended
Dec. 25, 2021
Revenue Net sales disaggregated by significant products and services for the three months
ended December 25, 2021 and December 26, 2020 were as follows (in millions): Three
Financial Instruments
Investments, All Other Investments [Abstract]
Financial Instruments
3 Months Ended
Dec. 25, 2021
Financial Instruments Cash, Cash Equivalents and Marketable Securities The following tables
show the Company’s cash, cash equivalents and marketable securities by significant
Condensed Consolidated Financial Statement Details
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidated Financial Statement Details
3 Months Ended
Dec. 25, 2021
Condensed Consolidated Financial Statement Details The following tables show the
Company’s condensed consolidated financial statement details as of December 25, 2021 and
Debt
Debt Disclosure [Abstract]
Debt
3 Months Ended
Dec. 25, 2021
Debt Commercial Paper The Company issues unsecured short-term promissory notes
(“Commercial Paper”) pursuant to a commercial paper program. The Company uses net
Shareholders' Equity
Equity [Abstract]
Shareholders' Equity
3 Months Ended
Dec. 25, 2021
Shareholders’ Equity Share Repurchase Program As of December 25, 2021, the Company was
authorized to purchase up to $315 billion of the Company’s common stock under a share
Benefit Plans
Share-based Payment Arrangement [Abstract]
Benefit Plans
3 Months Ended
Dec. 25, 2021
Benefit Plans Restricted Stock Units A summary of the Company’s restricted stock unit (“RSU”)
activity and related information for the three months ended December 25, 2021 is as follows:
Commitments and Contingencies
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
3 Months Ended
Dec. 25, 2021
Commitments and Contingencies Accrued Warranty The following table shows changes in the
Company’s accrued warranties and related costs for the three months ended December 25,
Segment Information and Geographic Data
Segment Reporting [Abstract]
Segment Information and Geographic Data
3 Months Ended
Dec. 25, 2021
Segment Information and Geographic Data The following table shows information by
reportable segment for the three months ended December 25, 2021 and December 26, 2020
Summary of Significant Accounting Policies (Policies)
Basis of Presentation and Preparation
Fiscal Period
Fair Value Measurements
3 Months Ended
Dec. 25, 2021
Basis of Presentation and Preparation The condensed consolidated financial statements

include the accounts
The Company’s fiscalof Apple
year Inc.52-
is the andorits wholly period
53-week ownedthat subsidiaries (collectively
ends on the “Apple”
last Saturday of or
September. An additional
Level 1 fair value estimatesweek is included
are based in theprices
on quoted first fiscal quarter
in active everyfor
markets five or six years
identical to
assets
or liabilities.Level 2 fair value estimates are based on observable inputs other than quoted
Summary of Significant Accounting Policies (Tables)
Computation of Basic and Diluted Earnings Per Share
3 Months Ended
Dec. 25, 2021
The following table shows the computation of basic and diluted earnings per share for the
three months ended December 25, 2021 and December 26, 2020 (net income in millions and
Revenue (Tables)
Net Sales Disaggregated by Significant Products and Services
3 Months Ended
Dec. 25, 2021
Net sales disaggregated by significant products and services for the three months ended
December 25, 2021 and December 26, 2020 were as follows (in millions): Three Months
Financial Instruments (Tables)
Investments, All Other Investments [Abstract]
Cash, Cash Equivalents and Marketable Securities by Significant Investment Category
Non-Current Marketable Debt Securities by Contractual Maturity
Notional Amounts of Outstanding Derivative Instruments
Carrying Amounts of Hedged Items in Fair Value Hedges
3 Months Ended
Dec. 25, 2021
The following tables show the Company’s cash, cash equivalents and marketable securities by
significant investment
The following category
table shows as value
the fair of December 25, 2021 and
of the Company’s September
non-current 25, 2021 (in
marketable debt
securities, by contractual maturity, as of December 25, 2021 (in millions): Due after
The notional amounts of the Company’s outstanding derivative instruments as of December 1 year
25, 2021 and September 25, 2021 were as follows (in millions): December 25, 2021
The carrying amounts of the Company’s hedged items in fair value hedges as of December 25,
2021 and September 25, 2021 were as follows (in millions): December 25, 2021 September
Condensed Consolidated Financial Statement Details (Tables)
Property, Plant and Equipment, Net
Other Non-Current Liabilities
Other Income/(Expense), Net
3 Months Ended
Dec. 25, 2021
Property, Plant and Equipment, Net December 25, September 25, Gross property, plant and
equipment $ 107,699
Other Non-Current $ 109,723
Liabilities Accumulated
December depreciation
25, September and amortization
25, Long-term (68,454)
taxes payable $ 24,689
$ 24,689 Other non-current liabilities 30,367 28,636 Total other non-current liabilities
Other Income/(Expense), Net The following table shows the detail of other income/(expense), $
net for the three months ended December 25, 2021 and December 26, 2020 (in millions):
Debt (Tables)
Debt Disclosure [Abstract]
Summary of Cash Flows Associated with Issuance and Maturities of Commercial Paper
3 Months Ended
Dec. 25, 2021
The following table provides a summary of cash flows associated with the issuance and
maturities of Commercial Paper for the three months ended December 25, 2021 and
Benefit Plans (Tables)
Restricted Stock Unit Activity
Summary of Share-Based Compensation Expense and the Related Income Tax Benefit
3 Months Ended
Dec. 25, 2021
A summary of the Company’s restricted stock unit (“RSU”) activity and related information for
the
Thethree months
following ended
table December
shows 25, 2021
share-based is as follows:
compensation Number
expense andof
theRSUs (in thousands)
related income tax
benefit included in the Condensed Consolidated Statements of Operations for the three
Commitments and Contingencies (Tables)
Commitments and Contingencies Disclosure [Abstract]
Changes in Accrued Warranties and Related Costs
3 Months Ended
Dec. 25, 2021
The following table shows changes in the Company’s accrued warranties and related costs for
the three months ended December 25, 2021 and December 26, 2020 (in millions): Three
Segment Information and Geographic Data (Tables)
Segment Reporting [Abstract]
Information by Reportable Segment
Reconciliation of Segment Operating Income to the Condensed Consolidated Statements of
Operations
3 Months Ended
Dec. 25, 2021
The following table shows information by reportable segment for the three months ended
December 25, 2021
A reconciliation and
of the Decembersegment
Company’s 26, 2020operating
(in millions): Three
income Months
to the Ended Consolidated
Condensed December 25,
Statements of Operations for the three months ended December 25, 2021 and December 26,
Summary of Significant Accounting Policies - Computation of Basic and Diluted
Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in
Millions
Numerator:
Net income
Denominator:
Weighted-average basic shares outstanding (in shares)
Effect of dilutive securities (in shares)
Weighted-average diluted shares (in shares)
Basic earnings per share (in dollars per share)
Diluted earnings per share (in dollars per share)
3 Months Ended
Dec. 25, 2021 Dec. 26, 2020
$ 34,630 $ 28,755
16,391,724 16,935,119
127,567 178,569
16,519,291 17,113,688
$ 2.11 $ 1.70
$ 2.10 $ 1.68
Revenue - Net Sales Disaggregated by Significant Products and Services (Details) - USD
($) $ in Millions
Disaggregation of Revenue [Line Items]
Net sales
Revenue recognized that was included in deferred revenue at the beginning of the period
iPhone
Net sales
Mac
Net sales
iPad
Net sales
Wearables, Home and Accessories
Net sales
Services
Net sales
3 Months Ended
Dec. 25, 2021 Dec. 26, 2020
$ 123,945 $ 111,439
3,000 2,500
71,628 65,597
10,852 8,675
7,248 8,435
14,701 12,971
$ 19,516 $ 15,761
Revenue - Additional Information (Details) - USD ($) $ in Billions Dec. 25, 2021
Total deferred revenue $ 12.4
Sep. 25, 2021
$ 11.9
Revenue - Deferred Revenue, Expected Timing of Realization (Details)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date
[Axis]:
Revenue,2021-12-26
Remaining Performance Obligation, Expected Timing of Satisfaction [Line
Items]
Deferred revenue, expected timing of realization, percentage
Deferred revenue, expected timing of realization, period
[Axis]:
Revenue,2023-01-01
Items]
[Axis]:
Revenue,2023-12-31
Items]
[Axis]:
Revenue,2024-12-29
Items]
Dec. 25, 2021
64.00%
1 year
27.00%
1 year
8.00%
1 year
1.00%
Financial Instruments - Cash, Cash Equivalents and Marketable Securities (Details) -
Debt Securities, Available-for-sale [Line Items]
Cash, Cash Equivalents and Marketable Securities, Adjusted Cost
Cash Equivalents and Marketable Securities, Unrealized Gains
Cash Equivalents and Marketable Securities, Unrealized Losses
Cash, Cash Equivalents and Marketable Securities, Fair Value
Cash and Cash Equivalents
Current Marketable Securities
Non-Current Marketable Securities
Total marketable securities that were restricted from general use
Level 1
Marketable Securities, Equity, Adjusted Cost
Marketable Securities, Equity, Unrealized Gains
Marketable Securities, Equity, Unrealized Losses
Marketable Securities, Equity, Fair Value
Level 2
Marketable Securities, Debt, Adjusted Cost
Marketable Securities, Debt, Unrealized Gains
Marketable Securities, Debt, Unrealized Losses
Marketable Securities, Debt, Fair Value
Cash
Cash
Money market funds | Level 1
Mutual funds | Level 1
Equity securities | Level 2
U.S. Treasury securities | Level 2
U.S. agency securities | Level 2
Non-U.S. government securities | Level 2
Certificates of deposit and time deposits | Level 2
Commercial paper | Level 2
Corporate debt securities | Level 2
Municipal securities | Level 2
Mortgage- and asset-backed securities | Level 2
Dec. 25, 2021 Sep. 25, 2021
$ 203,819 $ 189,961
1,071 1,753
2,294 1,198
202,596 190,516
37,119 34,940
26,794 27,699
138,683 127,877
16,800 17,900
11,571 9,783
16 11
(2) (1)
11,585 9,793
11,356 9,608
229 185
0 0
174,256 162,873
1,055 1,742
(2,292) (1,197)
173,019 163,418
7,771 8,027
26,565 27,514
138,683 127,877
17,992 17,305
17,992 17,305
0 0
0 0
11,356 9,608
0 0
0 0
11,356 9,608
11,356 9,608
0 0
0 0
215 175
16 11
(2) (1)
229 185
0 0
229 185
0 0
1,527 1,527
0 0
(850) (564)
677 963
0 0
677 963
0 0
29,221 22,878
64 102
(171) (77)
29,114 22,903
3,247 3,596
5,775 6,625
20,092 12,682
7,934 8,949
1 2
(116) (64)
7,819 8,887
1,066 1,775
1,581 1,930
5,172 5,182
18,983 20,201
160 211
(177) (101)
18,966 20,311
200 390
3,279 3,091
15,487 16,830
3,648 1,300
0 0
0 0
3,648 1,300
2,527 490
1,121 810
0 0
2,261 2,639
0 0
0 0
2,261 2,639
702 1,776
1,559 863
0 0
88,617 83,883
718 1,242
(754) (267)
88,581 84,858
29 0
11,665 12,327
76,887 72,531
993 967
10 14
(1) 0
1,002 981
0 0
150 130
852 851
21,072 20,529
102 171
(223) (124)
20,951 20,576
0 0
758 775
$ 20,193 $ 19,801
Financial Instruments - Non-Current Marketable Debt Securities by Contractual
Maturity (Details) $ in Millions
Fair value of non-current marketable debt securities by contractual maturity
Due after 1 year through 5 years
Due after 5 years through 10 years
Due after 10 years
Total fair value
Dec. 25, 2021USD ($)
$ 93,206
25,183
20,294
$ 138,683
Financial Instruments - Additional Information (Details) - Vendor
Trade receivables | Credit concentration risk | Cellular network carriers
Financial Instruments [Line Items]
Concentration risk, percentage
Non-trade receivables | Credit concentration risk
Number of vendors that individually represented 10% or more of total vendor non-trade
receivables
Non-trade receivables | Credit concentration risk | Vendor one
Non-trade receivables | Credit concentration risk | Vendor two
Non-trade receivables | Credit concentration risk | Vendor three
Hedges of foreign currency exposure associated with revenue and inventory purchases
Hedged foreign currency transactions, expected recognition period
Hedges of foreign currency exposure associated with term debt and marketable securities
Hedged foreign currency transactions, expected recognition period
3 Months Ended 12 Months Ended
Dec. 25, 2021 Sep. 25, 2021
45.00% 42.00%
3 3
54.00% 52.00%
13.00% 11.00%
12.00% 11.00%
12 months
21 years
Financial Instruments - Notional Amounts of Derivative Instruments (Details) - USD ($)
$ in Millions
Derivative instruments designated as accounting hedges | Foreign exchange contracts
Derivative [Line Items]
Derivatives, notional amount
Derivative instruments designated as accounting hedges | Interest rate contracts
Derivatives instruments not designated as accounting hedges | Foreign exchange contracts
Dec. 25, 2021 Sep. 25, 2021
$ 77,009 $ 76,475
16,875 16,875
$ 176,268 $ 126,918
Financial Instruments - Derivative Instruments Designated as Fair Value Hedges and
Related Hedged Items (Details) - USD ($) $ in Millions
Current and non-current marketable securities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying amount of hedged marketable securities
Current and non-current term debt
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying amount of hedged term debt
Dec. 25, 2021 Sep. 25, 2021
$ 15,322 $ 15,954
$ (17,444) $ (17,857)
Condensed Consolidated Financial Statement Details - Property, Plant and Equipment,
Net (Details) - USD ($) $ in Millions
Gross property, plant and equipment
Accumulated depreciation and amortization
Total property, plant and equipment, net
Dec. 25, 2021 Sep. 25, 2021
$ 107,699 $ 109,723
(68,454) (70,283)
$ 39,245 $ 39,440
Condensed Consolidated Financial Statement Details - Other Non-Current Liabilities
(Details) - USD ($) $ in Millions
Long-term taxes payable
Other non-current liabilities
Total other non-current liabilities
Dec. 25, 2021 Sep. 25, 2021
$ 24,689 $ 24,689
30,367 28,636
$ 55,056 $ 53,325
Condensed Consolidated Financial Statement Details - Other Income/(Expense), Net
Interest and dividend income
Interest expense
Other expense, net
Total other income/(expense), net
3 Months Ended
Dec. 25, 2021 Dec. 26, 2020
$ 650 $ 747
(694) (638)
(203) (64)
$ (247) $ 45
Debt - Additional Information (Details) - USD ($) $ in Millions Dec. 25, 2021
Debt Instrument [Line Items]
Commercial paper $ 5,000
Floating- and fixed-rate notes, aggregate carrying amount 117,800
Commercial paper
Commercial paper 5,000
Level 2
Floating- and fixed-rate notes, aggregate fair value $ 123,500
Sep. 25, 2021
$ 6,000
118,700
6,000
$ 125,300
Debt - Summary of Cash Flows Associated with Commercial Paper (Details) - USD ($) $
in Millions
Maturities 90 days or less:
Proceeds from commercial paper, net
Maturities greater than 90 days:
Proceeds from commercial paper
Repayments of commercial paper
Repayments of commercial paper, net
Total proceeds from/(repayments of) commercial paper, net
3 Months Ended
Dec. 25, 2021 Dec. 26, 2020
$ 1,339 $ 1,439
1,191 780
(3,530) (2,197)
(2,339) (1,417)
$ (1,000) $ 22
Shareholders' Equity - Additional Information (Details) shares in Millions
Share Repurchase Program [Line Items]
Amount authorized for repurchase of common stock (up to)
Number of shares repurchased (in shares) | shares
Amount of share repurchases
Share repurchase program, amount utilized
November 2021 accelerated share repurchase agreements
Share Repurchase Program [Line Items]
Number of shares repurchased (in shares) | shares
Amount of share repurchases
3 Months Ended
Dec. 25, 2021USD ($)shares
$ 315,000,000,000
124
$ 20,400,000,000
$ 274,500,000,000
30
$ 6,000,000,000
Benefit Plans - Additional Information (Details) - USD ($) $ in Billions
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost related to RSUs and stock options
Total unrecognized compensation cost related to RSUs and stock options, weighted-average
recognition period
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of RSUs as of the respective vesting dates
3 Months Ended
Dec. 25, 2021 Dec. 26, 2020
$ 20.6
3 years
$ 8.5 $ 8.5
Benefit Plans - Restricted Stock Units Activity and Related Information (Details) -
Restricted stock units $ / shares in Units, shares in Thousands, $ in Millions
Number of Restricted Stock Units
Beginning balance (in shares) | shares
RSUs granted (in shares) | shares
RSUs vested (in shares) | shares
RSUs canceled (in shares) | shares
Ending balance (in shares) | shares
Weighted-Average Grant Date Fair Value Per RSU
Beginning balance (in dollars per share) | $ / shares
RSUs granted (in dollars per share) | $ / shares
RSUs vested (in dollars per share) | $ / shares
RSUs canceled (in dollars per share) | $ / shares
Ending balance (in dollars per share) | $ / shares
Aggregate Fair Value
Aggregate fair value of RSUs | $
3 Months Ended
Dec. 25, 2021USD ($)$ / sharesshares
240,427
67,645
(56,649)
(4,886)
246,537
$ 75.16
147.33
61.75
93.21
$ 97.69
$ 43,460
Benefit Plans - Summary of Share-Based Compensation Expense and the Related
Income Tax Benefit (Details) - USD ($) $ in Millions
Share-based compensation expense
Income tax benefit related to share-based compensation expense
3 Months Ended
Dec. 25, 2021 Dec. 26, 2020
$ 2,265 $ 2,020
$ (1,536) $ (1,624)
Commitments and Contingencies - Changes in Accrued Warranties and Related Costs
Changes in Accrued Warranties and Related Costs [Roll Forward]
Beginning accrued warranty and related costs
Cost of warranty claims
Accruals for product warranty
Ending accrued warranty and related costs
3 Months Ended
Dec. 25, 2021 Dec. 26, 2020
$ 3,364 $ 3,354
(672) (723)
838 1,493
$ 3,530 $ 4,124
Segment Information and Geographic Data - Information by Reportable Segment
Segment Reporting Information [Line Items]
Net sales
Operating income
Americas
Net sales
Operating income
Europe
Net sales
Operating income
Greater China
Net sales
Operating income
Japan
Net sales
Operating income
Rest of Asia Pacific
Net sales
Operating income
3 Months Ended
Dec. 25, 2021 Dec. 26, 2020
$ 123,945 $ 111,439
41,488 33,534
51,496 46,310
19,585 15,785
29,749 27,306
11,545 9,589
25,783 21,313
11,183 8,530
7,107 8,285
3,349 3,503
9,810 8,225
$ 3,995 $ 2,953
Segment Information and Geographic Data - Reconciliation of Segment Operating
Income to the Condensed Consolidated Statements of Operations (Details) - USD ($) $ in
Millions
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to
Consolidated [Line Items]
Operating income
Research and development expense
Operating segments
Consolidated [Line Items]
Operating income
Segment reconciling items
Consolidated [Line Items]expense
Research and development
Corporate non-segment
Consolidated [Line
Other corporate Items]net
expenses,
3 Months Ended
Dec. 25, 2021 Dec. 26, 2020
$ 41,488 $ 33,534
(6,306) (5,163)
49,657 40,360
(6,306) (5,163)
$ (1,863) $ (1,663)

Cover Page - Shares Shares in Thousands Entity Information (Line Items)

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Cover Page - Shares Shares in Thousands Entity Information (Line Items)

Uploaded by

Copyright:

Available Formats

Cover Page - shares shares in Thousands

Entity Information [Line Items]

Common Stock, $0.00001 par value per share

1.000% Notes due 2022

1.375% Notes due 2024

0.000% Notes due 2025

0.875% Notes due 2025

1.625% Notes due 2026

2.000% Notes due 2027

1.375% Notes due 2029

3.050% Notes due 2029

0.500% Notes due 2031

3.600% Notes due 2042

Summary of Significant Accounting Policies Basis of Presentation and Preparation The

Basis of Presentation and Preparation The condensed consolidated financial statements

You might also like